The Scientific Advisory Board (SAB) provides strategic guidance and direction for our research and scientific programs. It plays a key role in guiding and prioritizing Oncoheroes' research investment.

 

PeterAdamson.png

Peter Adamson, MD, PhD

Chair Children’s Oncology Group

Professor of Pediatrics and Pharmacology, Children’s Hospital of Philadelphia

Patriti Bandopadhayay MBBS, PhD

Pediatric Neuro-Oncologist, Dana Farber Cancer Institute, Boston

Instructor in Pediatrics, Harvard School

Steven Dubois MD, MS

Director Experimental Therapeutics

Dana Farber Cancer Institute, Boston

Associate Professor of Pediatrics, Harvard School

JulietGray.jpg

Juliet Gray MD, MA, MB BS, MRCPCH, PhD

Clinical Lead Pediatric Oncology & Hematology Pediatric Oncology Clinical Trials Lead

Southampton Paediatric Oncology Centre

LeeHelman.jpg

Lee J. Helman, MD

Professor University of Southern California

Head Basic and Translational Research Children’s Center for Cancer and Blood Diseases, Children’s Hospital Los Angeles

JaroslavSterba.png

Jaroslav Sterba, MD, PhD

Department of Pediatric Oncology

University Hospital Brno, Czech Republic

Director of the CEPOETA Clinical Network